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STRUCTURED ABSTRACT: 
 
Background:  Small series have shown that cardiac resynchronization therapy (CRT) can 
be achieved in a majority of patients using exclusively cephalic venous access. We sought to 
determine whether this method is suitable for widespread use. 
Methods:  A group of 19 operators including 11 trainees in 3 pacing centres attempted to 
use cephalic access alone for all CRT device implants over a period of 8 years. The access 
route for each lead, the procedure outcome, duration and complications were collected 
prospectively. Data were also collected for 105 consecutive CRT device implants performed 
by experienced operators not using the exclusively cephalic method. 
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Results:  A new implantation of a CRT device using exclusively cephalic venous access 
was attempted in 1091 patients (73.6% male, aged 73±12 years). Implantation was achieved 
using cephalic venous access alone in 801 cases (73.4%) and using a combination of 
cephalic and other access in a further 180 (16.5%). Cephalic access was used for 
2468/3132 leads implanted (78.8%). Compared to a non-cephalic reference group, 
complications occurred less frequently (69/1091 vs 12/105; p=0.0468) and there were no 
pneumothoraces with cephalic implants. Procedure duration and fluoroscopy duration were 
shorter (procedure duration 118±45 vs 144±39 minutes, p<0.0001; fluoroscopy duration 
15.7±12.9 vs 22.8±12.2 minutes, p<0.0001). 
Conclusions: CRT devices can be implanted using cephalic access alone in a substantial 
majority of cases. This approach is safe and efficient. 
 
Key Words: Cephalic vein; venous cut down; Cardiac Resynchronization Therapy; 
Subclavian vein; Seldinger technique; Pneumothorax 
 
CONDENSED ABSTRACT 
Cardiac resynchronisation devices are usually implanted using venous puncture, creating a 
risk of pneumothorax or vascular injury. We have described an implantation method using 
exclusively cephalic venous access. We used this method in 1091 consecutive patients 
treated by 19 operators of varying experience. Procedures were safe and efficient with no 
pneumothorax or haemothorax. 
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INTRODUCTION 
Cardiac resynchronisation therapy (CRT) is an effective adjunct in the treatment of heart 
failure, widely indicated for prognostic and symptomatic benefit in the setting of systolic 
impairment(1). Implantation of CRT devices is technically demanding, associated with a 
significant risk of acute complications including a risk of pneumothorax of up to 5%(2–5). 
Subclavian access is associated with subclavian crush phenomenon and the use of extra-
thoracic axillary access is predictive of the development of lead failure(6).  
 
The use of direct venous cut down to access the cephalic vein in the deltopectoral groove 
eliminates the risk of pneumothorax, but it requires additional surgical skills. Although it is 
the first choice for simple pacing device implants it is not conventionally used for left 
ventricular lead implantation(7–9). Basic trigonometry dictates that the additional vein 
circumference needed to accommodate a third lead in the cephalic is minimal, as illustrated 
in the central figure; triple cephalic access for CRT is feasible in single center case series of 
up to 200 patients(9–11). Following a previous single-operator pilot study, here we report our 
experience rolling out the cephalic approach to include over 1,000 CRT implants by 
physicians of varying experience. 
 
METHODS 
Institutional ethical committee approval was obtained. From October 1st 2009, a group of 19 
implanting cardiologists in 3 neighbouring centres including operators of widely different 
levels of experience attempted to use exclusively cephalic access for all leads in all de novo 
CRT defibrillator (CRT-D) or CRT pacemaker (CRT-P) implants. Patient-related and 
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procedural data were collected prospectively in all patients. We evaluated the outcome of all 
CRT implantation procedures by this group. All operators self-reported their prior experience 
at CRT implant before starting the study. 
 
Implant technique 
After incising the skin and constructing a pocket for the generator, the cephalic vein was 
exposed in the deltopectoral groove. The distal end was tied off and a transverse venotomy 
performed. A 150-cm angled 0.97-mm hydrophilic guidewire (Radiofocus RF * GA35153M, 
Terumo Corporation, Tokyo, Japan) and two standard 50-cm 0.97-mm guidewires (St. Jude 
Medical, Minnetonka, MN, USA) were introduced into the cephalic vein and advanced 
toward the heart (figure 1). A left ventricular lead delivery system (Medtronic Attain LDS 
6216A, Medtronic Inc., Minneapolis, MN, USA) was advanced over the hydrophilic wire and 
used to perform contrast venography of the coronary sinus, then to position a pacing lead in 
a suitable cardiac vein. Right atrial and ventricular leads were then implanted using 7Fr peel-
away sheaths, or 9Fr for ICD leads, placed using a retained guidewire technique. Cephalic 
access was preserved until the end of the procedure. Significant cardiac pauses during CS 
lead placement were managed by unipolar pacing using a long guide wire. 
 
If the cephalic vein could not be identified or if it was found to be too small to accommodate 
all the leads required, a modified Seldinger technique was used to access the axillary or 
subclavian vein for one or more leads. We aimed to place as many leads as possible via the 
cephalic vein even if it was impossible to use it for all.  
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Post procedure care was at physician discretion but included as a minimum a chest 
radiograph and a device interrogation performed at 2-24 hours after implantation. 
 
Reference Group 
Five experienced operators in one of the participating centres declined to trial the fully 
cephalic technique, preferring to use either hybrid or fully subclavian access. Data from 
consecutive de novo CRT implant procedures undertaken by these operators were collected 
in the same way as for the operators using cephalic access and used as a non-cephalic CRT 
comparator group. Procedure reports, catheter lab electronic records and post procedure 
chest radiographs were used to determine procedure parameters and complications. 
 
Follow-up 
All patients were followed at intervals of not more than 12 months to check for pacing lead 
performance and the occurrence of complications. Any need for revision of any of the leads 
within the lifespan of the generator implanted on the index procedure was considered as a 
complication of that procedure. 
 
Statistics 
Statistical analysis was performed in Prism (GraphPad Software Inc., USA). Means of 
continuous data were compared using Student’s t-test and categorical data were compared 
using Fisher’s exact test or Pearson’s Chi squared where the expected count exceeded five. 
Bilateral p values less than 0.05 were considered significant. 
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RESULTS 
After exclusion of cases with insufficient data, the study group comprised 1091 consecutive 
CRT implantation procedures performed between October 1st 2009 and June 30th 2017 by a 
group of 19 operators including 11 trainees who attempted to use cephalic access 
exclusively for all procedures (table 1, figure 2). The non-cephalic comparator group 
comprised 105 implants by 5 operators collected over the same time period. 
 
Procedural success 
Implantation of all attempted leads was achieved at the index procedure in almost all 
patients (1083/1091; 99.3%); in a majority of patients (801/1091, 73.4%) this was done using 
cephalic venous access only. In a further 180/1091 (16.5%) of cases, one or more of the 
leads was implanted by the cephalic route, so that in total 2468/3132 (78.8%) of the leads 
implanted in this cohort were implanted via the cephalic route. The most successful (and 
most active) operator achieved full cephalic implants in 411/448 (91.7%) of cases. 
Two versus three lead systems 
The achievement of exclusively cephalic access was greater for systems that included an 
atrial lead (75.8% for 3-lead systems vs 66.9% for 2-lead systems; p=0.0330). Patients 
undergoing 2-lead implants were older (76.4±13.9yrs vs 72.7±12.4yrs; p=0.0017) and 2-lead 
procedures tended to be done more frequently by trainees (39/113 vs 148/958; p=0.0002). 
Predictors of cephalic success 
The proportion of implants accomplished by exclusively cephalic access was greater among 
accredited independent operators than trainees (75.5% vs 65.6%; p=0.0038) but no different 
in patients implanted with CRT-P compared to CRT-D (76.5% vs 72.0%; p=ns). Success at 
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achieving a full cephalic implant varied highly between operators, from 12.5% to 88.3% but 
as shown in figure 3, success rate for individual operators did not correlate with procedural 
volume (R2=0.04; p=ns) when trainees were included in the analysis. When trainees were 
excluded from the analysis, however, a trend to higher success with more volume was seen 
(R2=0.47) but the analysis was under-powered to reach statistical significance (p=ns). 
Operators’ CRT implant volume prior to the study period was, in general, far lower than their 
implant volume during the study period (range 0-200); implant volume prior to the study 
period was not predictive of volume during the study period (R2=0.17; p=ns), or of full 
cephalic success rate (R2=0.03; p=ns).  
 
Performance vs the non-cephalic access reference group 
105 de novo CRT implants performed by operators who declined to use the cephalic 
approach were identified over the study period. Patient characteristics were similar to the 
non-cephalic reference group. Accredited independent operators were over-represented in 
this group compared to the study group (table 1). Despite the more experienced operators in 
the reference group, procedure duration and fluoroscopy duration were significantly longer 
for non-cephalic procedures (procedure duration 118±45 vs 144±39 minutes, p<0.0001; 
fluoroscopy duration 15.7±12.9 vs 22.8±12.2 minutes, p<0.0001) and a greater proportion of 
procedures in the cephalic group were completed successfully within 2 hours (57% vs 21%, 
p<0.01, figure 4). 
Complications 
The overall incidence of complications was lower in the cephalic group compared to the non-
cephalic access reference group (table 2); there were no pneumothoraces in the cephalic 
access group. Despite the well-documented risk of symptomatic venous occlusion on the 
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ipsilateral upper limb, particularly with 3-lead systems, this complication was not reported 
following any implant.  
 
DISCUSSION 
This study shows that CRT can be delivered safely and efficiently using exclusively cephalic 
access in a majority of patients by a range of operators, and in a large proportion of patients 
by operators of varying levels of experience. Our series is the largest to date to address CRT 
implantation using solely cephalic access.  
 
Overall, our success at cephalic implantation was 73.4%, lower than other smaller series, 
including our own single operator pilot study(9–12). This probably represents the mixed 
experience levels in our group of implanters, and different levels of enthusiasm for the 
technique, compared to other reports including only experienced operators with a high level 
of commitment. The largest previously published series of 3-lead CRT implants included 171 
de novo implants achieving triple cephalic access in 87.7%, reflecting the extensive 
experience of a single operator at the McGill University Health Centre, QC, Canada(9). By 
comparison, our largest volume operator achieved triple cephalic access in 91.7% in the 
current case series. The main differences in implant technique between the McGill series 
and ours, are the order of lead placement, McGill’s use of three short peel-away sheaths in 
the cephalic, and that McGill leave the RA sheath and CS delivery system in situ until all 
leads are in place. An extra short sheath is presumably made necessary to maintain 
maneuverability of the CS delivery system when implanting the CS lead after the right 
ventricular lead. We avoid the need for a third short sheath by implanting the CS lead first 
via a delivery system without a short sheath and we slit the CS delivery system before 
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implanting RV then RA leads. We do not use an over-sized sheath (11Fr) for RV defibrillator 
lead placement as per the McGill method. 
 
Employing advanced methods such as venodilatation and use of specialized equipment can 
increase cephalic success rates to 96%(13–15). Counterintuitively, our full cephalic success 
rate was lower for 2-lead vs 3-lead CRT systems; this may be explained by the older 
population undergoing 2-lead system implants related to the increased prevalence of 
permanent atrial fibrillation with age, and also these implants tended to be undertaken more 
frequently by trainees.  
 
Previously, the largest single study comparing access methods for non-CRT implants found 
longer procedure times associated with the cephalic implant route than with a subclavian 
approach(16). We found the opposite, with shorter procedure and fluoroscopy times using 
the cephalic route, and a more reliable achievement of success within a reasonable 
procedure duration. 
 
The incidence of complications related to direct access to the subclavian or axillary vein is 
reduced when guided by ultrasound or by venography(17), but individual studies show risks 
of up to 5%(3,12,16). In contrast, a recent meta-analysis of pacing trials estimated the risk of 
pneumothorax with the cephalic approach 0.19%, related in most cases to use of a higher 
risk access method once cephalic access has failed(7). By implanting the CS lead first, in 
theory we risked higher rates of intraprocedural CS lead displacements, however the 
retention of guidewires for RA and RV lead placement meant that we were able to retain 
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cephalic access even after CS lead displacement and reduce conversion to higher risk 
access. The avoidance of pneumothorax is particularly vital in elderly patients, who are more 
than twice as prone to pneumothorax during pacing procedures(18) and be more severely 
affected by their occurrence. Our study confirms that using the cephalic route minimizes the 
risk of this complication. 
 
Although cephalic access is the preferred route of access for 61% of device implanting 
physicians in a recent EHRA survey, it was also reported that sole cephalic access is not 
commonly pursued for CRT implants (8). This appears to be due to concerns that the 
cephalic vein is unable to accommodate three leads, that lead maneuverability might be 
compromised, or that the process of cephalic cutdown could prolong procedures 
unnecessarily. Our experience suggests that these concerns are unfounded. 
 
LIMITATIONS 
This was a non-randomised series, with procedures performed by operators with substantial 
prior experience of CRT and of the use of cephalic venous cut-down, or by trainees 
supervised by experienced operators. Operator activity varied significantly, with the most 
active performing over 500 implants and the least active under 10. Varying operator 
experience may have contributed to differences in success rates in the cephalic implants vs 
the non-cephalic reference group. However very high success rates were achieved across a 
range of operators with the cephalic approach. 
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CONCLUSION 
CRT devices can be implanted using cephalic access alone in a majority of cases. This 
approach is safe and efficient. 
 
ACKNOWLEDGEMENTS 
Sue Jones and Tamara Daily contributed to the collection of data. 
 
REFERENCES 
1.  Normand C, Linde C, Singh J, Dickstein K. Indications for 
Cardiac Resynchronization Therapy. JACC Hear Fail [Internet]. 2018 Apr 1 [cited 
2019 Mar 31];6(4):308–16. Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S2213177918301203 
2.  Olechowski B, Sands R, Zachariah D, Andrews NP, Balasubramaniam R, Sopher M, 
et al. Is cardiac resynchronisation therapy feasible, safe and beneficial in the very 
elderly? J Geriatr Cardiol [Internet]. 2015 Sep [cited 2016 Aug 11];12(5):497–501. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26512240 
3.  Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of 
permanent pacemaker implantation: no difference between dual and single chamber 
systems. Br Heart J [Internet]. 1995 Jun 1 [cited 2019 Feb 9];73(6):571–5. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/7626359 
4.  Șoșdean R, Pescariu S, Enache B, Macarie R, Marca R. Implantation of Biventricular 
Cardiac Devices Using a Double Venous Approach — An Alternative Implantation 
  
 
This article is protected by copyright. All rights reserved. 
 
Technique. Acta Medica Marisiensis [Internet]. 2014 Apr 1 [cited 2019 Mar 
31];60(2):57–60. Available from: 
http://content.sciendo.com/view/journals/amma/60/2/article-p57.xml 
5.  Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. Pneumothorax 
in cardiac pacing: a population-based cohort study of 28,860 Danish patients. 
Europace [Internet]. 2012 Aug 1 [cited 2019 Apr 13];14(8):1132–8. Available from: 
https://academic.oup.com/europace/article-lookup/doi/10.1093/europace/eus054 
6.  Aizawa Y, Negishi M, Kashimura S, Nakajima K, Kunitomi A, Katsumata Y, et al. 
Predictive factors of lead failure in patients implanted with cardiac devices. Int J 
Cardiol [Internet]. 2015 Nov 15 [cited 2019 Apr 13];199:277–81. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/26218183 
7.  Benz AP, Vamos M, Erath JW, Hohnloser SH. Cephalic vs. subclavian lead 
implantation in cardiac implantable electronic devices: a systematic review and meta-
analysis. EP Eur [Internet]. 2019 Jan 1 [cited 2019 Mar 31];21(1):121–9. Available 
from: https://academic.oup.com/europace/article/21/1/121/5055370 
8.  Bongiorni MG, Proclemer A, Dobreanu D, Marinskis G, Pison L, Blomstrom-Lundqvist 
C, et al. Preferred tools and techniques for implantation of cardiac electronic devices 
in Europe: results of the European Heart Rhythm Association survey. Europace 
[Internet]. 2013 Nov 1 [cited 2019 Apr 1];15(11):1664–8. Available from: 
https://academic.oup.com/europace/article-lookup/doi/10.1093/europace/eut345 
9.  Hadjis A, Proietti R, Essebag V. Implantation of cardiac resynchronization therapy 
devices using three leads by cephalic vein dissection approach. EP Eur [Internet]. 
2017 Sep 1 [cited 2019 Mar 31];19(9):1514–20. Available from: 
https://academic.oup.com/europace/article/19/9/1514/3073886 
  
 
This article is protected by copyright. All rights reserved. 
 
10.  Romeyer-Bouchard C, Da Costa A, Abdellaoui L, Messier M, Thévenin J, Afif Z, et al. 
Simplified cardiac resynchronization implantation technique involving right access and 
a triple-guide/single introducer approach. Hear Rhythm [Internet]. 2005 Jul [cited 2019 
Apr 1];2(7):714–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15992727 
11.  Ussen B, Dhillon PS, Anderson L, Beeton I, Hickman M, Gallagher MM. Safety and 
Feasibility of Cephalic Venous Access for Cardiac Resynchronization Device 
Implantation. Pacing Clin Electrophysiol [Internet]. 2011 Mar 1 [cited 2016 Aug 
11];34(3):365–9. Available from: http://doi.wiley.com/10.1111/j.1540-
8159.2010.02975.x 
12.  Vogler J, Geisler A, Gosau N, Hakmi S, Willems S, Rassaf T, et al. Triple lead 
cephalic versus subclavian vein approach in cardiac resynchronization therapy device 
implantation. Sci Rep [Internet]. 2018 Dec 7 [cited 2019 Mar 31];8(1):17709. Available 
from: http://www.nature.com/articles/s41598-018-35994-0 
13.  Kolettis TM, Lysitsas DN, Apostolidis D, Baltogiannis GG, Sourla E, Michalis LK. 
Improved ―cut-down‖ technique for transvenous pacemaker lead implantation. 
Europace [Internet]. 2010 Sep 1 [cited 2019 Apr 1];12(9):1282–5. Available from: 
https://academic.oup.com/europace/article-lookup/doi/10.1093/europace/euq173 
14.  Gonna H, Domenichini G, Zuberi Z, Adhya S, Sharma R, Anderson LJ, et al. Femoral 
implantation and pull through as an adjunct to traditional methods in cardiac 
resynchronization therapy. Hear Rhythm [Internet]. 2016 Jun [cited 2019 Apr 
13];13(6):1260–5. Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S1547527116001272 
15.  Domenichini G, Zuberi Z, Gallagher MM. A pacing lead repositioned without incising 
the skin: a simplified approach. Europace [Internet]. 2014 Feb 1 [cited 2019 Apr 
  
 
This article is protected by copyright. All rights reserved. 
 
13];16(2):305. Available from: https://academic.oup.com/europace/article-
lookup/doi/10.1093/europace/eut273 
16.  Calkins H, Ramza BM, Brinker J, Atiga W, Donahue K, Nsah E, et al. Prospective 
Randomized Comparison of the Safety and Effectiveness of Placement of 
Endocardial Pacemaker and Defibrillator Leads Using the Extrathoracic Subclavian 
Vein Guided by Contrast Venography Versus the Cephalic Approach. Pacing Clin 
Electrophysiol [Internet]. 2001 Apr 1 [cited 2019 Feb 9];24(4):456–64. Available from: 
http://doi.wiley.com/10.1046/j.1460-9592.2001.00456.x 
17.  Liccardo M, Nocerino P, Gaia S, Ciardiello C. Efficacy of ultrasound-guided 
axillary/subclavian venous approaches for pacemaker and defibrillator lead 
implantation: a randomized study. J Interv Card Electrophysiol [Internet]. 2018 Mar 15 
[cited 2019 Apr 1];51(2):153–60. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/29335840 
18.  Mikhaylov EN, Lebedev DS. Cardiac resynchronization in the elderly is beneficial, but 
could we implant our devices in old patients safer? J Geriatr Cardiol [Internet]. 2016 
Mar [cited 2019 Apr 13];13(3):277–8. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/27103926 
 
FIGURE LEGENDS 
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Central illustration: The calculation of the perimeter of a vein tightly wrapped around two 
close packed leads can be solved using trigonometric methods. Circles ⊙A and ⊙B with 
radii R_A and R_B; there will be two external bitangent lines and the point of intersect of 
these lines with the circle radii will define a major and minor arc for both circles. The total 
vein perimeter (blue) is equal to the sum of the lengths of the external tangent line segments 
and exterior circular arcs. With the addition of a third lead, or circle, the exterior arcs of 
interest are no longer divided equally by a simple reflection through a line connecting the 
circle centres so that the angles of the exterior arcs are derived from additional input values 
that can be acquired in a stepwise manner. Solving these equations for two or three leads 
reveals the additional vein perimeter required to accommodate the third lead is equivalent to 
a 0.7Fr upsize in the vein – not, we would suggest, a material consideration. 
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Figure 1: Photographs of a pacing procedure performed by our cephalic implant technique. 
The cephalic vein is isolated and ligated distally and a short guidewire is placed through it to 
the right atrium (1A), followed by one other short guidewire and a 150cm hydrophilic guide 
wire. A delivery system is advanced over the hydrophilic wire (1B). After implantation of the 
left ventricular lead the delivery system is split and removed, and a sheath is inserted over 
one of the short guide wires for implantation of the right ventricular lead (1C). A 7F sheath is 
then advanced over the final guide wire and used to position the atrial lead (1D). In each 
case, the sheath is removed before the next lead is advanced. 
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Figure 2: Venous access techniques used in the cephalic access study and reference 
groups. 290 / 1099 (26%) of cephalic access study group procedures had one or more leads 
implanted via a non-cephalic route, vs 105 / 105 (100%) of reference group procedures. 
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Figure 3: Relationship between success at full cephalic implant technique and procedural 
volume by first operator implanters in the study group. No correlation is demonstrated with 
Spearman’s test for all operators but when analysis is restricted to accredited specialists 
alone there is a correlation (R2=0.47) albeit this does not reach statistical significance due to 
under-powering. 
 
 
Figure 4: Distribution of procedure duration in the cephalic access study and reference 
groups. Procedures were significantly shorter in the study group than the reference group 
(p<0.0001). 
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Table 1: Baseline characteristics of the study cohort and reference group. Patients are well 
matched between the groups except for prior cardiac surgery. The study group procedures 
were shorter in duration and fluoroscopy use and had a lesser proportion of experienced 
operators. Continuous variables are presented as mean ± SD, discrete variables as number 
(percentage). 
 Cephalic  
Group 
Reference 
Group 
p 
N 1091 105  
Patient Characteristics:    
Age (/yrs) 73±12 72±12 0.3035 
Male sex 803 (73.6%) 79 (79.1%) 0.2451 
Prior cardiac surgery 262 (24.0%) 16 (15.2%) 0.0420 
Prior system or lead extraction 21 (1.9%) 0 0.1515 
Prior failed implant attempt 3 (0.3%) 0 >0.9999 
Procedure Characteristics: 
   
CRT-D implants 616 (56.5%) 67 (63.8%) 0.1462 
Two lead systems (no atrial lead) 133 (12.2%) 13 (12.4%) 0.9546 
Procedure duration (minutes) 118±45 144±39 <0.0001 
Fluoroscopy duration (minutes) 15.7±12.9 22.8±12.2 <0.0001 
Experienced operator 904 (82.3%) 105 (100%) <0.0001 
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Table 2: Procedural complications in the study cohort and a reference group. A higher 
proportion of the reference group experienced complications, though this was not statistically 
significant except for failure to place the CS lead. One procedure in the reference group led 
to two complications, counted as a single complicated procedure for the ―any complication‖ 
total. 
Complications: Cephalic 
Group  
Reference 
Group 
p 
N   1091 105  
Need for CS lead replacement or reposition 37 (3.4%) 3 (2.9%) >0.9999 
Replacement or reposition of other lead 13 (1.2%) 3 (2.9%) 0.1595 
Failed CS lead implant 8 (0.7%) 4 (3.8%) 0.0160 
Pocket or wound complication 4 (0.4%) 0 >0.9999 
Infection requiring removal or extraction 6 (0.6%) 1 (1.0%) 0.4753 
Pneumothorax requiring drainage 0 1 (1.0%) 0.0878 
Pericardial effusion requiring drainage 1 (0.1%) 1 (1.0%) 0.1679 
Symptomatic venous occlusion of upper limb 0 0 >0.9999 
Any complication 69 (6.3%) 12 (11.4%) 0.0468 
 
